Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.
This study has been completed.
Information provided by:
First received: August 8, 2008
Last updated: May 10, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||February 2010 (Final data collection date for primary outcome measure)|